NEW YORK (GenomeWeb) – Fluidigm and Visiopharm have signed a comarketing agreement to automate image analysis for imaging mass cytometry, the companies said today.

Under the agreement, Fluidigm and Visiopharm will copromote Visiopharm's Phenomap image-analysis software alongside Fluidigm's Hyperion imaging system, MCD Viewer software, and related Maxpar antibodies and kits.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.